Galderma Laboratories, L.P., announced today that the U.S. Food and Drug Administration has approved Differin® Gel, 0.3%, a new, higher concentration formulation of Differin® 0.1%, a topical retinoid indicated for the treatment of acne.
From: biz.yahoo.com
adapalene) Gel, 0.3% for Acne
Posted by Ruslan Abuzant at 9:26 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment